Matthew Parker Ph.D.

Matt’s Profile

Matt is an Associate in the Intellectual Property & Technology, Corporate and Litigation practices at Maynard Cooper. He assists clients with a variety of intellectual property matters including the licensing, protection, and enforcement of copyrights, patents, trademarks and trade secrets.

Matt earned his Ph.D. in Biomedical Sciences with a concentration in Immunology.  He also completed research in the fields of immunology, translational medicine, molecular biology and analytical chemistry, which serves as the backbone to his understanding of the variety of complex scientific and technical matters required when working on behalf of his clients to protect their intellectual property.

Matt also has experience working on general corporate matters related to company formation, mergers & acquisitions and equity offerings.

He received his J.D. from Emory University School of Law. He holds a Ph.D. from the University of Florida College of Medicine and a B.S. from the University of Florida.

Matt’s Affiliations & Civic Involvement


  • Alabama Bar Association (Intellectual Property, Entertainment, & Sports Law Section)
  • BioAlabama
  • Fly Quest
State Bar:Alabama
U.S. District Court:Alabama(Northern)
U.S. Patent & Trademark Office
Emory University School of Law (2013, J.D., TI:GER (joint technology commercialization program with Georgia Tech); Emory International Law Review, Symposium Editor; IP Society, Executive Board)
University of Florida, College of Medicine (2008, Ph.D., Biomedical Sciences w/concentration in Immunology; Alumni Fellowship)
University of Florida (2003, B.S., Microbiology & Cell Science; National Merit Scholar, Honors Program; University Scholars Program)
Government Solutions Webinar Small Business Bid Strategies - Pricing, Teaming Agreements, and Subcontracts
Jon Levin, Jon Hall and Matt Parker presented a webinar on April 27 regarding Small Business Bid Strategies: Pricing, Teaming Agreements, and Subcontracts.  Jon Levin is a shareholder and member of Maynard Cooper's Government C...
Rabbit Polyclonal Anti-Mouse Thymocyte Globulin Administration Alters Dendritic Cell Profile and Function in NOD Mice to Suppress Diabetogenic Responses
Exendin-4 treatment of nonobese diabetic mice increases beta-cell proliferation and fractional insulin reactive area
Human Alpha 1-Antitrypsin Therapy Induces Fatal Anaphylaxis in NOD Mice